Note 19—Subsequent Events

Operating Lease

On August 6, 2026, the Company renewed its lease for the office space in Tel Aviv for a one-year term through October 2027.

Future minimum lease payments related to this lease renewal are as follows (in thousands):

DataSeeds expansion supported by a $7.7 Million Direct Investment and the Appointment of a New CEO

On August 31, 2026, the Company announced a significant expansion of its DataSeeds.AI (“DataSeeds”) strategy, supported by an approximately $7.5 million direct investment led by Vice Chairman Howard Jonas. Additionally, Morris Berger has been appointed as Chief Executive Officer, effective October 1, 2026. Jonathan Reich will continue serving as Zedge’s CEO through September 30, 2026, and will transition to President and Chief Operating Officer upon Mr. Berger’s appointment.

On September 25, 2026, the Company completed the private placement contemplated by the direct investment mentioned above. At the closings thereunder, the Company issued an aggregate of 2,616,447 shares (or $2.93 average price per share) of Class B Common Stock and warrants to purchase an aggregate of 2,354,803 shares of Class B Common Stock (the “Warrants”) for aggregate gross proceeds of $7.68 million.

The warrants have an average exercise price of $3.22 and become exercisable only on the later of: (i) the date of receipt of the requisite stockholder approval under NYSE American rules; and (ii) the applicable six-month period following issuance.

Plan Amendment

On September 8, 2026, the Company’s Board of Directors amended, subject to approval of the amendment by the Company’s stockholders, the Company’s 2026 Stock Option and Incentive Plan to increase the number of shares of the Company’s Class B common stock available for the grant of awards thereunder by an additional 1,100,000 shares to an aggregate of 1,538,695 shares.

DSU Vesting

On September 7, 2026, 26,142 DSUs granted under the incentive program discussed in Note 12 above vested (the second tranche of the 89,683 DSUs granted in November 2024). In connection with the vesting of the DSUs, the Company issued 26,142 shares of Class B common stock (based on a 100% conversion ratio determined due to the market price of $2.98 per share relative to the grant price approved by the Compensation Committee of the Company’s Board of Directors of $2.76 per share).